Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study
- PMID: 14623596
- DOI: 10.1016/s0731-7085(03)00229-2
Simultaneous high-performance liquid chromatographic assay of furosemide and propranolol HCL and its application in a pharmacokinetic study
Abstract
A practical, sensitive, selective and efficient reversed-phase high-performance liquid chromatographic (HPLC) method is reported for the determination of two commonly used antihypertensive drugs, furosemide and propranolol hydrochloride. The drugs were eluted through a Nucleosil C(18) column with a mobile phase composed of 0.02 M potassium dihydrogen phosphate and acetonitrile (80:20, v/v) adjusted to pH 4.5 and the effluent from the column was monitored at 235 nm. The present method enabled simple and isocratic HPLC with UV detection of these drugs in raw materials and in pharmaceutical formulations. These procedures were also applied for the assay of furosemide in rabbits' plasma, using propranolol hydrochloride as an internal standard. The linear concentration range of the assay was 0.1-200 and 5-200 microg ml(-1) for furosemide and propranolol hydrochloride, respectively. The inter and intra-day assay precision and accuracy showed reproducibility and good linearity (r(2)>0.99). The method retained its accuracy and precision when applying the standard addition technique. The results obtained by applying the proposed method was statistically analysed and compared with those obtained by the reported methods.
Similar articles
-
High-performance liquid chromatographic determination of furosemide in plasma and urine and its use in bioavailability studies.J Chromatogr B Biomed Sci Appl. 1998 Jun 12;710(1-2):121-8. doi: 10.1016/s0378-4347(98)00058-9. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9686878 Clinical Trial.
-
Comparison of two extraction methods for determination of propranolol and furosemide in human plasma by mixed-mode chromatography.J Pharm Biomed Anal. 1996 Feb;14(4):475-81. doi: 10.1016/0731-7085(95)01652-x. J Pharm Biomed Anal. 1996. PMID: 8729647
-
Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection.Biomed Chromatogr. 2001 Dec;15(8):539-45. doi: 10.1002/bmc.110. Biomed Chromatogr. 2001. PMID: 11748690
-
Development and validation of a stability-indicating HPLC assay method for simultaneous determination of spironolactone and furosemide in tablet formulation.J Chromatogr Sci. 2012 Sep;50(8):721-6. doi: 10.1093/chromsci/bms062. Epub 2012 May 28. J Chromatogr Sci. 2012. PMID: 22641089
-
Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies.J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jul 5;806(2):277-82. doi: 10.1016/j.jchromb.2004.04.009. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15171939
Cited by
-
Validated reverse-phase high-performance liquid chromatography for quantification of furosemide in tablets and nanoparticles.J Anal Methods Chem. 2013;2013:207028. doi: 10.1155/2013/207028. Epub 2013 Sep 16. J Anal Methods Chem. 2013. PMID: 24163777 Free PMC article.
-
Simultaneous determination of labetalol and furosemide by first-derivative synchronous spectrofluorimetry.J Fluoresc. 2009 Sep;19(5):817-28. doi: 10.1007/s10895-009-0479-6. Epub 2009 May 1. J Fluoresc. 2009. PMID: 19408106
-
Quantitative analysis of propranolol hydrochloride by high performance thin layer chromatography.Indian J Pharm Sci. 2008 May-Jun;70(3):395-8. doi: 10.4103/0250-474X.43016. Indian J Pharm Sci. 2008. PMID: 20046758 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources